Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 43063-407

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 43063-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063407)

Label for ORPHENADRINE CITRATE ER 100 mg extended-release oral tablets by PD-Rx Pharmaceuticals, Inc. The package contains 20 tablets. The label includes the NDC 43063-407-20, batch LOT C22A11, and expiration date 03/2024. It carries warnings about dizziness, not crushing or chewing the tablets, and keeping the product out of reach of children.*

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Chemical structure of orphenadrine citrate showing the molecular arrangement of its active ingredient. The diagram includes the core components of orphenadrine attached to the citrate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.